Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Quest Diagnostics

    NYSE: DGX · Real-Time Price · USD
    182.06
    1.85 (1.03%)
    At close: Jun 16, 2025, 3:59 PM
    182.00
    -0.03%
    After-hours: Jun 16, 2025, 07:48 PM EDT

    Quest Diagnostics Statistics

    Share Statistics

    Quest Diagnostics has 111.64M shares outstanding. The number of shares has increased by -0.1% in one year.

    Shares Outstanding

    n/a
    		 111.64M

    Shares Change (YoY)

    n/a
    		 -0.1%

    Shares Change (QoQ)

    n/a
    		 -0.57%

    Owned by Institutions (%)

    n/a
    		 89.2%

    Shares Floating

    n/a
    		 111.01M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,763

    FTD / Avg. Volume

    n/a
    		 0.22%

    Short Selling Information

    The latest short interest is 3.82M, so 3.43% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.82M

    Short % of Shares Out

    n/a
    		 3.43%

    Short % of Float

    n/a
    		 3.91%

    Short Ratio (days to cover)

    n/a
    		 3.11

    Valuation Ratios

    The PE ratio is 19.23 and the forward PE ratio is 17.13. Quest Diagnostics's PEG ratio is 6.95.

    PE Ratio

    n/a
    		 19.23

    Forward PE

    n/a
    		 17.13

    PS Ratio

    n/a
    		 1.7

    Forward PS

    n/a
    		 1.9

    PB Ratio

    n/a
    		 2.47

    P/FCF Ratio

    n/a
    		 18.42

    PEG Ratio

    n/a
    		 6.95
    Financial Ratio History

    Enterprise Valuation

    Quest Diagnostics has an Enterprise Value (EV) of 23.28B.

    EV / Sales

    n/a
    		 2.36

    EV / EBITDA

    n/a
    		 12.29

    EV / EBIT

    n/a
    		 17.45

    EV / FCF

    n/a
    		 25.61

    Financial Position

    The company has a current ratio of 1.1, with a Debt / Equity ratio of 1.05.

    Current Ratio

    n/a
    		 1.1

    Quick Ratio

    n/a
    		 1.02

    Debt / Equity

    n/a
    		 1.05

    Debt / EBITDA

    n/a
    		 3.74

    Debt / FCF

    n/a
    		 7.8

    Interest Coverage

    n/a
    		 5.96

    Financial Efficiency

    Return on Equity is 12.85% and Return on Invested Capital is 6.92%.

    Return on Equity

    n/a
    		 12.85%

    Return on Assets

    n/a
    		 5.39%

    Return on Invested Capital

    n/a
    		 6.92%

    Revenue Per Employee

    n/a
    		 $179,490.91

    Profits Per Employee

    n/a
    		 $15,836.36

    Employee Count

    n/a
    		 55,000

    Asset Turnover

    n/a
    		 0.61

    Inventory Turnover

    n/a
    		 35.26

    Taxes

    Income Tax

    n/a
    		 273M

    Effective Tax Rate

    n/a
    		 23.23%

    Stock Price Statistics

    The stock price has increased by 32.87% in the last 52 weeks. The beta is 0.49, so Quest Diagnostics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.49

    52-Week Price Change

    n/a
    		 32.87%

    50-Day Moving Average

    n/a
    		 173

    200-Day Moving Average

    n/a
    		 162.63

    Relative Strength Index (RSI)

    n/a
    		 67.68

    Average Volume (20 Days)

    n/a
    		 1,259,196

    Income Statement

    In the last 12 months, Quest Diagnostics had revenue of 9.87B and earned 871M in profits. Earnings per share was 7.8.

    Revenue

    n/a
    		 9.87B

    Gross Profit

    n/a
    		 3.24B

    Operating Income

    n/a
    		 1.35B

    Net Income

    n/a
    		 871M

    EBITDA

    n/a
    		 1.89B

    EBIT

    n/a
    		 1.4B

    Earnings Per Share (EPS)

    n/a
    		 7.8
    Full Income Statement

    Balance Sheet

    The company has 549M in cash and 7.09B in debt, giving a net cash position of -6.54B.

    Cash & Cash Equivalents

    n/a
    		 549M

    Total Debt

    n/a
    		 7.09B

    Net Cash

    n/a
    		 -6.54B

    Retained Earnings

    n/a
    		 9.36B

    Total Assets

    n/a
    		 15.8B

    Working Capital

    n/a
    		 634M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.33B and capital expenditures -425M, giving a free cash flow of 909M.

    Operating Cash Flow

    n/a
    		 1.33B

    Capital Expenditures

    n/a
    		 -425M

    Free Cash Flow

    n/a
    		 909M

    FCF Per Share

    n/a
    		 8.19
    Full Cash Flow Statement

    Margins

    Gross margin is 32.86%, with operating and profit margins of 13.63% and 8.82%.

    Gross Margin

    n/a
    		 32.86%

    Operating Margin

    n/a
    		 13.63%

    Pretax Margin

    n/a
    		 11.9%

    Profit Margin

    n/a
    		 8.82%

    EBITDA Margin

    n/a
    		 19.19%

    EBIT Margin

    n/a
    		 13.63%

    FCF Margin

    n/a
    		 9.21%

    Dividends & Yields

    DGX pays an annual dividend of $3.85, which amounts to a dividend yield of 1.72%.

    Dividend Per Share

    n/a
    		 $3.85

    Dividend Yield

    n/a
    		 1.72%

    Dividend Growth (YoY)

    n/a
    		 5.63%

    Payout Ratio

    n/a
    		 48.61%

    Earnings Yield

    n/a
    		 5.2%

    FCF Yield

    n/a
    		 5.43%
    Dividend Details

    Analyst Forecast

    The average price target for DGX is $185, which is 1.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $185

    Price Target Difference

    n/a
    		 1.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 14
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $39

    Lynch Upside

    n/a
    		 -78.58%

    Graham Number

    n/a
    		 103.83

    Graham Upside

    n/a
    		 -42.97%

    Stock Splits

    The last stock split was on Jun 21, 2005. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Jun 21, 2005

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 3.14

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist